(Q72426645)
Statements
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer (English)
L T Vlasveld
S Horenblas
A Hekman
A M Hilton
A C Dubbelman
C J Melief
1 February 1994